Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Masatake Tanaka

Showing results (31-40 of 49) with videos related to

Pageof 5
Sort By:
Cancer Chemotherapy and Pharmacology|October 23, 2020
Association of lenvatinib plasma concentration with clinical efficacy and adverse events in patients with hepatocellular carcinomaKojiro Hata, Kimitaka Suetsugu, Nobuaki Egashira, et al.
Toxicology and Applied Pharmacology|December 10, 2021
Pirfenidone attenuates acetaminophen-induced liver injury via suppressing c-Jun N-terminal kinase phosphorylationShigeki Tashiro, Masatake Tanaka, Takeshi Goya, et al.
Canadian Journal of Gastroenterology & Hepatology|January 14, 2020
Clinical Features of Liver Injury Induced by Immune Checkpoint Inhibitors in Japanese PatientsKoji Imoto, Motoyuki Kohjima, Tomonobu Hioki, et al.
Cancers|December 30, 2025
Gemcitabine + Cisplatin + S-1 Treatment for Advanced Cholangiocarcinoma: Cost-Effective, with Better Progression-Free Survival Versus Standard Treatment with Gemcitabine + Cisplatin + DurvalumabYusuke Morita, Rie Sugimoto, Miho Kurokawa, et al.
BMC Gastroenterology|December 17, 2025
Clinicopathological features of steroid-refractory immune-mediated hepatotoxicity induced by immune checkpoint inhibitorsTomonobu Hioki, Koji Imoto, Takeshi Goya, et al.
Molecular Medicine Reports|November 27, 2012
Reduction of fatty acid oxidation and responses to hypoxia correlate with the progression of de-differentiation in HCCMasatake Tanaka, Yuko Masaki, Kosuke Tanaka, et al.
BMC Gastroenterology|February 17, 2021
Discriminant equation using mucosally expressed cytokines and transcription factor for making definite diagnosis of inflammatory bowel disease unclassifiedHiroaki Okuno, Haruei Ogino, Eikichi Ihara, et al.
BMC Gastroenterology|May 7, 2025
Strain elastography for detecting advanced Fontan-associated liver disease: a retrospective studyKoji Imoto, Takeshi Goya, Yuki Azuma, et al.
Medicine|March 10, 2023
Transcatheter arterial steroid injection therapy improves the prognosis of patients with acute liver failureAkifumi Kuwano, Tasuku Okui, Motoyuki Kohjima, et al.
Biorxiv : the Preprint Server for Biology|January 27, 2025
Liver Lymphatic Dysfunction as a Driver of Fibrosis and Cirrhosis ProgressionJain Jeong, Shao-Jung Hsu, Daiki Horikami, et al.
Pageof 5

Showing results (31-40 of 49) with videos related to

Sort By:
Pageof 5
Cancer Chemotherapy and Pharmacology|October 23, 2020
Association of lenvatinib plasma concentration with clinical efficacy and adverse events in patients with hepatocellular carcinomaKojiro Hata, Kimitaka Suetsugu, Nobuaki Egashira, et al.
Toxicology and Applied Pharmacology|December 10, 2021
Pirfenidone attenuates acetaminophen-induced liver injury via suppressing c-Jun N-terminal kinase phosphorylationShigeki Tashiro, Masatake Tanaka, Takeshi Goya, et al.
Canadian Journal of Gastroenterology & Hepatology|January 14, 2020
Clinical Features of Liver Injury Induced by Immune Checkpoint Inhibitors in Japanese PatientsKoji Imoto, Motoyuki Kohjima, Tomonobu Hioki, et al.
Cancers|December 30, 2025
Gemcitabine + Cisplatin + S-1 Treatment for Advanced Cholangiocarcinoma: Cost-Effective, with Better Progression-Free Survival Versus Standard Treatment with Gemcitabine + Cisplatin + DurvalumabYusuke Morita, Rie Sugimoto, Miho Kurokawa, et al.
BMC Gastroenterology|December 17, 2025
Clinicopathological features of steroid-refractory immune-mediated hepatotoxicity induced by immune checkpoint inhibitorsTomonobu Hioki, Koji Imoto, Takeshi Goya, et al.
Molecular Medicine Reports|November 27, 2012
Reduction of fatty acid oxidation and responses to hypoxia correlate with the progression of de-differentiation in HCCMasatake Tanaka, Yuko Masaki, Kosuke Tanaka, et al.
BMC Gastroenterology|February 17, 2021
Discriminant equation using mucosally expressed cytokines and transcription factor for making definite diagnosis of inflammatory bowel disease unclassifiedHiroaki Okuno, Haruei Ogino, Eikichi Ihara, et al.
BMC Gastroenterology|May 7, 2025
Strain elastography for detecting advanced Fontan-associated liver disease: a retrospective studyKoji Imoto, Takeshi Goya, Yuki Azuma, et al.
Medicine|March 10, 2023
Transcatheter arterial steroid injection therapy improves the prognosis of patients with acute liver failureAkifumi Kuwano, Tasuku Okui, Motoyuki Kohjima, et al.
Biorxiv : the Preprint Server for Biology|January 27, 2025
Liver Lymphatic Dysfunction as a Driver of Fibrosis and Cirrhosis ProgressionJain Jeong, Shao-Jung Hsu, Daiki Horikami, et al.
Pageof 5